August 27, 2020
Kowa said on August 26 that its Rho kinase inhibitor Glanatec ophthalmic solution (ripasudil) was approved in Thailand for the treatment of open-angle glaucoma and ocular hypertension. Originated by Nagoya-based drug discovery startup D. Western Therapeutics Institute, Glanatec has been...read more